A UK court invalidated two GSK patents in a Pfizer dispute, reinforcing Pfizer’s RSV vaccine position. This ruling may influence ongoing global legal battles, particularly outside the U.S.
A UK court invalidated two GSK patents in a Pfizer dispute, reinforcing Pfizer’s RSV vaccine position. This ruling may influence ongoing global legal battles, particularly outside the U.S.